Comparative effects of paclitaxel and rapamycin on smooth muscle migration and survival: role of AKT-dependent signaling

Arteriosclerosis, Thrombosis, and Vascular Biology
Cam PattersonPeter Charles

Abstract

Advances in stent technology have enabled the delivery of drugs to improve outcomes after stent deployment. However, the optimal payloads for stents are not clear, and the appropriate stent-based therapies for high-risk patients, such as diabetics, have not been clearly established. We used smooth muscle cell culture models to compare the activities of rapamycin and paclitaxel. Smooth muscle cells were grown in normal or high glucose to induce insulin resistance. Both paclitaxel and rapamycin activate mitogen-activated protein kinase pathways similarly. However, rapamycin potently activates AKT-dependent signaling, an effect that overrides the downregulation of this pathway by insulin resistance and that causes phosphorylation of the AKT-dependent transcription factor FOXO1. This effect is associated with attenuation of the anti-migratory effects of rapamycin under high glucose conditions that are not observed with paclitaxel, as well as with increased protection against ceramide-induced cytotoxicity, both of which are dependent on FOXO1 phosphorylation. Differences between the ability of rapamycin and paclitaxel to activate AKT may account for their differential cell survival and antichemotactic activities. These observations ...Continue Reading

References

Nov 15, 1996·The Journal of Clinical Investigation·M PoonA R Marks
Mar 20, 1999·The Journal of Biological Chemistry·L E Rameh, L C Cantley
May 18, 2001·American Journal of Physiology. Heart and Circulatory Physiology·S K MoonC Patterson
Nov 28, 2001·The Journal of Biological Chemistry·Nicole A BourbonMark Kester
Dec 26, 2001·Proceedings of the National Academy of Sciences of the United States of America·F RintelenE Hafen
Oct 3, 2003·The New England Journal of Medicine·Jeffrey W MosesUNKNOWN SIRIUS Investigators
Jan 16, 2004·The New England Journal of Medicine·Gregg W StoneUNKNOWN TAXUS-IV Investigators
Jul 16, 2004·Cell Cycle·Mikhail V BlagosklonnyRobert A Herrmann
Aug 13, 2004·Cardiovascular Research·Andrew J CarterRobert Falotico
Feb 19, 2005·Science·D D SarbassovDavid M Sabatini
May 4, 2005·Circulation·Marco A Costa, Daniel I Simon
Jun 21, 2005·The Journal of Surgical Research·Irfan I GalariaMark G Davies
Aug 18, 2005·The New England Journal of Medicine·Stephan WindeckerBernhard Meier
Aug 18, 2005·The New England Journal of Medicine·Alban DibraUNKNOWN ISAR-DIABETES Study Investigators

❮ Previous
Next ❯

Citations

Jan 27, 2011·Heart and Vessels·Michiaki HigashitaniNobuhisa Hagiwara
May 25, 2012·Cardiovascular Intervention and Therapeutics·Toshiki SawaiMasaaki Ito
Oct 12, 2012·Cardiovascular Intervention and Therapeutics·Hiroaki TsujitaYouichi Kobayashi
Sep 7, 2011·European Heart Journal·Marco RoffiA Pieter Kappetein
Mar 5, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Yu KataokaYoritaka Otsuka
Dec 19, 2013·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Si-Hyuck KangHyo-Soo Kim
May 18, 2007·The Journal of Investigative Dermatology·Christiane ThallingerChristian Joukhadar
Oct 30, 2015·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Simone GrottiLeonardo Bolognese
Aug 18, 2012·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Sun-Joo JangSeung-Jung Park
Nov 8, 2014·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·R RomagueraA Cequier
Jun 12, 2014·Circulation. Cardiovascular Interventions·Anwer HabibAloke V Finn
Dec 17, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Björn HegnerDuska Dragun
Oct 9, 2013·Circulation·Ehrin J ArmstrongJason H Rogers
Dec 25, 2009·Circulation. Cardiovascular Quality and Outcomes·Maria ChiuJack V Tu
Oct 23, 2008·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Jung-Sun KimUNKNOWN Korean Multicenter Angioplasty Team (KOMATE) Investigators
Sep 15, 2010·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Anikó PósaMariann Gyöngyösi
Apr 11, 2012·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Ana LaynezRon Waksman
Nov 5, 2014·Coronary Artery Disease·Sebastian Kufner, Adnan Kastrati
Jun 12, 2013·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Sebastian KufnerAdnan Kastrati
Jan 30, 2016·Circulation Journal : Official Journal of the Japanese Circulation Society·Jiro AokiUNKNOWN XIEVCE V/PROMUS PMS Investigators
Apr 21, 2016·Cardiovascular and Interventional Radiology·J M AbadalMiguel Araujo
Mar 31, 2020·The Journal of Thoracic and Cardiovascular Surgery·Naoki MasakiYoshikatsu Saiki
May 10, 2021·Biomedical Engineering Online·Joseph Robert StevensMohammad Akrami
Oct 18, 2011·International Journal of Cardiology·Daisuke KamoiToyoaki Murohara

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.